Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 18, 2015

Drug Name Review Type Class Manufacturer
Viekira Pak New Drug Initial Review Hepatitis C AbbVie
Zontivity New Drug Initial Review Platelet Aggregation Inhibitor Merck
Harvoni New Drug Initial Review Hepatitis C Gilead
Savaysa New Drug Initial Review Anticoagulant Daiichi Sankyo
Grastek New Drug Initial Review Allergen Extract Merck
Ragwitek New Drug Initial Review Allergen Extract Merck
Plegridy New Drug Initial Review Multiple Sclerosis Biogen Idec
Orbactiv New Drug Initial Review Antibiotic The Medicines Company